Current knowledge about AD pathology comes extensively from studies on familial early-onset AD (fAD or EOAD) with defined and penetrant mutations in amyloid peptide precursor protein (APP), presenilin 1 (PS1), and presenilin 2 (PS2) [88,89,90]. This evidence concerns the gene PSEN1 and Alzheimer disease.